Research Article | Open Access
Harisankar Singha, Sachin K. Goyal, Praveen Malik, Raj K. Singh, "Use of Heavy Water (D2O) in Developing Thermostable Recombinant p26 Protein Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Equine Infectious Anemia Virus Infection", The Scientific World Journal, vol. 2014, Article ID 620906, 6 pages, 2014. https://doi.org/10.1155/2014/620906
Use of Heavy Water (D2O) in Developing Thermostable Recombinant p26 Protein Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Equine Infectious Anemia Virus Infection
Thermostabilizing effect of heavy water (D2O) or deuterium oxide has been demonstrated previously on several enzymes and vaccines like oral poliovirus vaccine and influenza virus vaccine. In view of the above observations, effect of heavy water on in situ thermostabilization of recombinant p26 protein on enzyme-linked immunosorbent assay (ELISA) for serodiagnosis of equine infectious anemia virus (EIAV) infection was investigated in the present study. The carbonate-bicarbonate coating buffer was prepared in 60% and 80% D2O for coating the p26 protein in 96-well ELISA plate and thermal stability was examined at 4°C, 37°C, 42°C, and 45°C over a storage time from 2 weeks to 10 months. A set of positive serum () consisting of strong, medium, and weak titer strength (4 samples in each category) and negative serum () were assessed in ELISA during the study period. At each time point, ELISA results were compared with fresh plate to assess thermal protective effect of D2O. Gradual increase in the stabilizing effect of 80% D2O at elevated temperature (37°C < 42°C < 45°C) was observed. The 80% D2O provides the thermal protection to rp26 protein in ELISA plate up to 2 months of incubation at 45°C. The findings of the present study have the future implication of adopting cost effective strategies for generating more heat tolerable ELISA reagents with extended shelf life.
Preserving quality of the biological macromolecules like vaccine, enzymes, antigens, antibody, and so forth is one of most important but difficult tasks as potency and stability of biological molecules are lost in a temperature and time-dependent fashion. Maintaining strict cold chain during manufacture, storage, transportation, and field utilization of these biological macromolecules is necessary for getting optimal effect. Harsh field environment due to high ambient temperature and extensive power shortage are going to make the task more challenging in the future. Various formulation strategies to enhance the temperature stability of vaccines and adjuvant are being explored in different laboratories across the globe. Among these methods, generic expression of recombinant vaccine candidates fused with heat stable protein [1, 2] and heterologous expression of protein in maize seeds  have been proved to improve solubility and thermostability of recombinant proteins. Efficacy of chemical stabilizers lactalbumin hydrolysate-sucrose on the thermostability of a live-attenuated peste des petits ruminants (PPR) vaccine had previously been demonstrated [4, 5]. Role of heavy water (D2O) in biological sciences especially in thermostabilization of vaccines has been thoroughly reviewed . The first experimental evidence of D2O mediated thermostabilization was demonstrated in yellow fever 17D vaccines . Later, the potential of D2O was extensively studied for thermostabilization of oral polio virus vaccine [8–11]. Subsequently, many candidate biomolecules including influenza virus vaccine , peste des petits ruminants vaccine , haemorrhagic septicaemia vaccine , and enzymes like lactate dehydrogenase, hexokinase, and creatine kinase  were used to investigate the thermostabilizing effect of D2O.
Thorough search and scan of the literature revealed that most of the thermostabilization research was focused on vaccines. Till date, no information on thermostabilization of proteins using D2O in enzyme-linked immunosorbent assay (ELISA) is available. However, stabilization of proteins with synthetic stabilizers and molecular chaperons has been reported [16, 17]. Because of inherent problem of limited shelf life of commercial diagnostic reagents especially protein and antibody at temperature higher than recommended storage temperature, enhancing protein stability at high temperature is becoming increasingly demanded. In the present study, the protective thermostable effect of D2O on recombinant p26 protein (rp26) in ELISA for diagnosis of equine infectious anemia (EIA) was investigated with the aim of developing thermostable ELISA.
2. Materials and Methods
2.1. Serum Panel
To evaluate the test performance, sets of reference serum and field serum maintained in the serum repository of NRCE were used. Serum samples () positive for EIAV antibodies were used as positive control which included seven reference positive (NVSL Ames, IA, USA; VMRD, Pullman, WA, USA; and IDEXX, Westbrook, USA) and five EIAV-infected equine serums collected in routine diagnosis process under the institute’s serosurveillance programme.
According to the anti-p26 antibody titer strength, positive serum samples were designated as strong (), medium (), and weak positive () serums. A panel of 30 known negative serum samples from NRCE repository and reference negative control () serum (VMRD, Pullman, WA, USA) was also included in the assay.
2.2. Indirect ELISA Using Heavy Water (D2O)
Indirect ELISA using recombinant EIAV p26 protein was used as described previously . The rp26 (200 ng/well) was coated in 96-well ELISA plate (Greiner Bio One, USA) using standard carbonate-bicarbonate coating buffer (Sigma-Aldrich, St. Louis, USA) prepared in H2O, 60% D2O (v/v), or 80% D2O (v/v). After blocking the plates with 6% skim milk in PBS-T (200 μL/well) for 1 h at 37°C, plates were washed twice with PBS-T. Total 48 plates were coated with each buffer and labeled, and 12 plates from each buffer were incubated at four temperatures (4°C, 37°C, 42°C, and 45°C) for developing at defined time interval (from 2 weeks to 10 months).
To determine the thermostable effect of heavy water, fresh plate was coated with rp26 protein with standard coating buffer and developed along with experimental plates at each time point following the methods described earlier. Serum samples were tested in duplicate. The whole experiment was repeated twice over a period of 2 years.
2.3. Data Analysis
ELISA results obtained in each time interval were compared with fresh rp26 coated plate. The absorbance data (OD values) was normalized to eliminate interplate variations and make data comparable across the plates using the following formula: “percent positivity /”. The optimum cut-off value of the ELISA was determined by receiver operative curves (ROC) analysis using value . Thermostable effect of heavy water on rp26 in different temperature was determined as a function of value. Comparative analysis of value and statistical significance was determined by Student’s -test.
3.1. Evaluation of Thermostable Effect of D2O on rp26 ELISA at Different Storage Time and Incubation Temperature
In fresh plate, average % value for strong, medium, and weak positive serums was 128, 93, and 41 throughout the study period. Cut-off value of the ELISA was 22 as determined earlier . At 4°C, value of strong positive serum obtained with coating buffer either prepared in H2O- or 60%, and 80% D2O-ranged from 121 at 2 weeks to 103 at 10 months. Up to 8 months, the value (111) of strong positive serum in these buffers did not vary significantly with fresh plate ELISA () (Figure 1). For medium positive serum, the value gradually decreases from 91 to 78, while for weak positive serum, the value ranged from 37 to 29 during the observation period. The value obtained with all the serums was above the cut-off point during the study period.
At 37°C in H2O coating buffer, value of strong positive serum significantly decreased from 114 at 2 months () to 53 at 10 months () while the value for medium and weak positive serums touched the cut-off point at 5 months and 6 weeks, respectively. In 60% and 80% D2O coating buffer, strong positive serum values fall from 113 at 6 weeks to 41 at 10 months. Like H2O coating buffer, the value for medium and weak positive serums touched the cut-off point at 6 months and 6 weeks, respectively, in D2O coating buffer at 37°C (Figure 2(a)).
At 42°C in H2O coating buffer, value of strong positive serum significantly decreased from 116 at 1 month () to 45 at 10 months () while the value for medium and weak positive serum touched the cut-off point at 7 months and 2 months, respectively. In 60% and 80% D2O coating buffer, strong positive serum values significantly fall from 115 and 111 at 6 weeks (, 0.06) to 46 and 59 at 10 months (, 0.007), respectively. The value for medium and weak positive serums touched the cut-off point at 9 months and 6 weeks, respectively, in 60% D2O coating buffer at 42°C (Figure 2(b)). In 80% D2O, the value touched the cut-off point at 7 months and 2 months for medium and weak positive serums, respectively.
In H2O coating buffer, no significant difference in value of strong, medium, and weak positive serums (115, 79, and 32, resp.) at 1 month was observed between 45°C and 42°C. The value of strong and medium positive serums (111 and 80 at 6 weeks) was slightly but significantly stable in 60% D2O than in the H2O coating buffer at 45°C (Figure 3). The value of weak positive serum touched the cut-off point at 6 weeks in both H2O and 60% D2O buffers. values of strong, medium, and weak positive serums were 111, 78, and 33, respectively, at 2 months in 80% D2O at 45°C. The value of weak positive serum touched the cut-off point at 4 months in 80% D2O buffer.
Heavy water, formally called deuterium oxide or D2O, is a form of water that contains hydrogen isotope deuterium (D) rather than the common hydrogen-1 isotope (H) that makes up most of the hydrogen in normal water (H2O). The effects of D2O on living systems or biological macromolecules are exerted in two ways. The first one is “solvent isotope effect” which acts on the structure of water and the biological macromolecules. The other one is “deuterium isotope effect” where D2O replaces H with D in biological molecules . The C–D bond is several times stronger than the C–H bond and thus more resistant to enzymatic and even chemical cleavage. This property has been utilized to enhance the thermostability of oral polio vaccine [9, 19], which shows D2O reconstituted vaccine and remains biologically active even if the cold chain is disturbed for a while. Later on, the same strategy has been adopted for stabilization of influenza vaccine , PPR vaccine , and haemorrahagic septicemia vaccine .
This paper describes for the first time in situ thermostabilization of equine infectious anemia virus (EIAV) recombinant p26 protein based indirect ELISA using D2O. Stabilizing effect was determined as a function of maintenance of statistically significant value over a storage time and temperature in comparison to freshly coated rp26 plate. It is important to mention that any diagnostic ELISA should be validated with varying strength of known positive serum to cover the broader range of diagnostic capacity, to improve the accuracy of diagnosis, or to avoid false negative findings. Therefore, in the present study, we have included three categories of positive serum differing in titer strength (strong, medium, and weak). It has been demonstrated that value of rp26 ELISA varies with serum strength (antibody titer), storage time, incubation temperature, and stability of protein in higher temperature. Although the values of strong, medium, and weak positive serums were above the cutoff at a given point, there was a significant deviation of the values in comparison to those in freshly coated plates. Therefore, to determine the actual duration of thermostability without compromising the overall diagnostic efficiency of ELISA, weak positive serum showing value equal to or statistically non-significantly different from that of fresh plate at given time point was considered.
Analysis of results demonstrated that rp26 in H2O or 60%, and 80% D2O based coating buffer was very stable at 4°C up to 5 months. Further, heavy water did not appear to have any stabilizing effect on protein at freezing temperature which is corroborated by earlier experiment in influenza vaccine . It appears that it is possible to store rp26 coated and dried ELISA plate at 4°C up to 5 months and it could be used for diagnostic purpose. Drastic reduction in rp26 stability corresponding with steep decrease in value was observed at 37°C. There was no clear association between percentage of D2O and thermostable effect on ELISA at 37°C. D2O-based coating buffer was able to maintain diagnostically significant value up to 6 weeks for strong positive serum and 1 month for medium positive and weak positive serums (Figure 1).
Time- and temperature-dependent decrease in values is accelerated at higher temperature (42°C and 45°C) in the presence in of H2O-based coating buffer than in D2O-based coating buffer. The value of all positive serum significantly declined () after 1 month in H2O coated plate. The rp26 protein yields diagnostically comparable value with strong positive serum till 6 weeks at 42°C in D2O coating buffer (Figure 3). However, for medium and weak positive serum protective effect of D2O on rp26 protein was observed till 1 month at 42°C. Again, concentration of D2O had no significant effect on rendering thermal protection to rp26 protein at 42°C. The greatest degree of stabilization was obtained with the highest concentration (80%) of D2O at 45°C. The 80% D2O provides the thermal protection to rp26 protein in ELISA plate up to 2 months of incubation at 45°C. Among the three coating buffers, 80% D2O buffer was found to have the most thermostable effect at 45°C, followed by 60% D2O as compared to H2O.
No difference in stability of rp26 protein between 42°C and 45°C in H2O coating buffer was found. However, thermal tolerance of rp26 protein at elevated temperature for a month in H2O-based coating buffer suggests that rp26 protein could remain stable at 42°C or 45°C up to certain period (1 month), whenever 80% D2O enhances the thermal protection to rp26 protein up to 2 months at higher temperature (45°C). The protective effect of the 80% D2O was more evident at 45°C temperature than that of 60% D2O. Gradual increase in the stabilizing effect of 80% D2O at elevated temperature () observed in the present study correlates with previous findings where ~90% deuterium oxide results in a significant increase in the stability of the polio and influenza virus incubated at 37°C, 42°C, 45°C, or 56°C [8, 12]. To elucidate the mechanism of action of D2O on stabilizing, the recombinant protein was beyond the scope of the study. However, it may be inferred from the earlier investigations that D2O may have rendered the protective effects to rp26 by providing structural rigidity to protein molecules due to the greater strength of noncovalent oxygen-deuterium or nitrogen-deuterium bonds relative to the corresponding hydrogen bonds resulting in slowing down of degradative reaction [10, 12, 19, 20].
This strategy of stabilizing protein using D2O seems to be applicable to a wide range of assays involving recombinant proteins. The utility of this strategy may be limited at present; however, this is a step forward towards developing a thermostable immunoassay suitable for tropical countries and can serve as an alternative support system for cold chain. In the present study, rp26 was exposed to D2O only for 16 h; long-term exposure to D2O might have better thermostable effect which needs further verification. The findings of the present study have the future implication of adopting cost effective strategies for generating more heat tolerable ELISA reagents with extended shelf life.
Conflict of Interests
The authors declare that they have no conflict of interests.
The authors thank Indian Council of Agricultural Research (ICAR) for financial assistance to carry out the research project. Kind help of Heavy Water Board, Department of Atomic Energy, Government of India, for providing heavy water is highly acknowledged.
- A. De Marco, E. Casatta, S. Savaresi, and A. Geerlof, “Recombinant proteins fused to thermostable partners can be purified by heat incubation,” Journal of Biotechnology, vol. 107, no. 2, pp. 125–133, 2004.
- H. Huang, J. Liu, and A. D. Marco, “Induced fit of passenger proteins fused to Archaea maltose binding proteins,” Biochemical and Biophysical Research Communications, vol. 344, no. 1, pp. 25–29, 2006.
- C. A. Hayden, E. M. Egelkrout, A. M. Moscoso et al., “Production of highly concentrated, heat-stable hepatitis B surface antigen in maize,” Plant Biotechnology Journal, vol. 10, no. 8, pp. 979–984, 2012.
- J. Sarkar, B. P. Sreenivasa, R. P. Singh, P. Dhar, and S. K. Bandyopadhyay, “Comparative efficacy of various chemical stabilizers on the thermostability of a live-attenuated peste des petits ruminants (PPR) vaccine,” Vaccine, vol. 21, no. 32, pp. 4728–4735, 2003.
- T. Riyesh, V. Balamurugan, A. Sen et al., “Evaluation of efficacy of stabilizers on the thermostability of live attenuated thermo-adapted Peste des petits ruminants vaccines,” Virologica Sinica, vol. 26, no. 5, pp. 324–337, 2011.
- A. Sen, V. Balamurugan, K. K. Rajak, S. Chakravarti, V. Bhanuprakash, and R. K. Singh, “Role of heavy water in biological sciences with an emphasis on thermostabilization of vaccines,” Expert Review of Vaccines, vol. 8, no. 11, pp. 1587–1602, 2009.
- M. Barme, B. Vacher, M. L. Ryhiner, and G. Chabannier, “Thermostabilization of lyophilized 17D malaria vaccine. II. Pilot batches prepared under conditions of industrial production,” Journal of Biological Standardization, vol. 15, no. 1, pp. 67–72, 1987.
- R. Wu, M.-M. Georgescu, F. Delpeyroux et al., “Thermostabilization of live virus vaccines by heavy water (D2O),” Vaccine, vol. 13, no. 12, pp. 1058–1063, 1995.
- J. B. Milstien, S. M. Lemon, and P. F. Wright, “Development of a more thermostable poliovirus vaccine,” Journal of Infectious Diseases, vol. 175, supplement 1, pp. S247–S253, 1997.
- C.-H. Chen, R. Wu, L. G. Roth, S. Guillot, and R. Crainic, “Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2,” Archives of Biochemistry and Biophysics, vol. 342, no. 1, pp. 108–116, 1997.
- B. Verheyden, K. Andries, and B. Rombaut, “Capsid and RNA stabilisation of the oral polio vaccine,” Vaccine, vol. 19, no. 15-16, pp. 1899–1905, 2001.
- M. R. Ikizler and P. F. Wright, “Thermostabilization of egg grown influenza viruses,” Vaccine, vol. 20, no. 9-10, pp. 1393–1399, 2002.
- A. Sen, Development and evaluation of a thermostable pest des petits ruminants (PPR) vaccine using heavy water (D2O) [Ph.D. thesis], universtiy Indian Veterinary Research Institute, Izatnagar, India, 2009.
- R. S. Gandge and A. A. Sherikar, “Thermostabilizing property of deuterium oxide in haemorrhagic septicaemia vaccine,” Indian Journal of Comparative Microbiology Immunology and Infectious Disease, vol. 31, no. 1-2, pp. 59–61, 2010.
- U. Lemm and M. Wenzel, “Stabilisation of enzymes and antisera by heavy water (author's transl),” European Journal of Biochemistry, vol. 116, no. 3, pp. 441–445, 1981.
- M. Ehrnsperger, C. Hergersberg, U. Wienhues, A. Nichtl, and J. Buchner, “Stabilization of proteins and peptides in diagnostic immunological assays by the molecular chaperone Hsp25,” Analytical Biochemistry, vol. 259, no. 2, pp. 218–225, 1998.
- S. Sakaki, N. Nakabayashi, and K. Ishihara, “Stabilization of an antibody conjugated with enzyme by 2-methacryloyloxyethyl phosphorylcholine copolymer in enzyme-linked immunosorbent assay,” Journal of Biomedical Materials Research, vol. 47, no. 4, pp. 523–528, 1999.
- H. Singha, S. K. Goyal, P. Malik, S. K. Khurana, and R. K. Singh, “Development, evaluation, and laboratory validation of Immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus,” Indian Journal of Virology, vol. 24, no. 3, pp. 349–356, 2013.
- J. F. E. Newman, S. Tirrell, C. Ullman, P. G. Piatti, and F. Brown, “Stabilising oral poliovaccine at high ambient temperatures,” Vaccine, vol. 13, no. 15, pp. 1431–1435, 1995.
- J. F. E. Newman, P. G. Piatti, B. M. Gorman et al., “Foot-and-mouth disease virus particles contain replicase protein 3D,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 2, pp. 733–737, 1994.
Copyright © 2014 Harisankar Singha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.